<DOC>
	<DOCNO>NCT00087399</DOCNO>
	<brief_summary>RATIONALE : Gabapentin may effective relieve hot flash woman breast cancer concern take hormone therapy treat hot flash . It yet know whether gabapentin effective without antidepressant treat hot flash . PURPOSE : This randomized phase III trial study gabapentin antidepressant see well work compare antidepressant alone treat hot flash woman breast cancer concern take hormone treat hot flash .</brief_summary>
	<brief_title>Gabapentin With Without Antidepressants Treating Hot Flashes Women Who Have Had Breast Cancer Have Concerns About Taking Hormone Therapy</brief_title>
	<detailed_description>OBJECTIVES : - Compare efficacy gabapentin v without antidepressant , measure frequency intensity hot flash , patient history breast cancer concern take hormonal therapy due fear develop breast cancer . - Compare adverse event patient treat regimen . - Correlate reduction hot flash score improvement quality life relate outcomes patient treat regimen . OUTLINE : This randomize , multicenter study . Patients stratify accord duration hot flash symptom ( &lt; 9 month vs ≥ 9 month ) , average frequency hot flash per day ( 2-3 v 4-9 v ≥ 10 ) , antidepressant currently use ( venlafaxine v paroxetine v ) . Patients randomize 1 2 treatment arm . - Arm I : Patients continue receive antidepressant ( study entry ) week 1-5 . During week 2-5 , patient also receive oral gabapentin daily day 8-10 , twice daily day 11-13 , three time daily day 14-35 absence unacceptable toxicity . - Arm II : Patients receive gabapentin arm I . Patients taper antidepressant 7-10 day remain gabapentin alone ( per arm I schedule ) . Patients arms complete hot flash diary baseline daily study treatment . Quality life assess baseline weekly study treatment . PROJECTED ACCRUAL : A total 110 patient ( 55 per treatment arm ) accrue study within 2 year .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Hot Flashes</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<mesh_term>Gabapentin</mesh_term>
	<mesh_term>gamma-Aminobutyric Acid</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : History breast cancer OR concern take hormonal therapy due fear develop breast cancer Experiencing bothersome hot flash , define patientreported occurrence ≥ 14 time per week AND sufficiently severe prompt desire additional therapeutic intervention despite current use antidepressant Currently ( ≥ 2 week ) treat stable dose antidepressant No monoamine oxidase inhibitor tricyclics No current evidence malignant disease Hormone receptor status : Not specify PATIENT CHARACTERISTICS : Age 18 Sex Female Performance status ECOG 01 Life expectancy At least 6 month Other Not pregnant nursing Negative pregnancy test Fertile patient must use effective barrier contraception PRIOR CONCURRENT THERAPY : Chemotherapy More 4 week since prior antineoplastic chemotherapy No concurrent antineoplastic chemotherapy Endocrine therapy More 4 week since prior androgen , estrogen , progestational agent More 2 week since prior dehydroepiandrosterone ( DHEA ) treatment hot flash No concurrent androgens , estrogen , progestational agent , include oral contraceptive No concurrent DHEA treatment hot flash Concurrent tamoxifen , raloxifene , aromatase inhibitor therapy allow stable dose least 4 week prior study entry study treatment Other No prior gabapentin More 2 week since prior treatment hot flash ( e.g. , clonidine BellergalS® ) Concurrent vitamin E soy supplement allow stable dose least 1 month prior study entry study treatment No concurrent treatment hot flash ( e.g. , clonidine BellergalS® ) No concurrent antidepressant</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>breast cancer</keyword>
	<keyword>hot flash</keyword>
</DOC>